4
Changes in Ownership
AbbVie Inc. Filed Acc 0001415889-25-004463
EVP, R&D and CSO acquired 10,555 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thakkar Roopal EVP, R&D and CSO | 2025-02-13 | Grant or award | +3,595 | 39,994 | D | ||
| Thakkar Roopal EVP, R&D and CSO | 2025-02-13 | Grant or award | +1,474 | 41,468 | D | ||
| Thakkar Roopal EVP, R&D and CSO | 2025-02-13 | Grant or award | +2,138 | 43,606 | D | ||
| Thakkar Roopal EVP, R&D and CSO | 2025-02-13 | Grant or award | +3,348 | 46,954 | D | ||
| Derivatives | |||||||
| Thakkar Roopal EVP, R&D and CSO | 2025-02-13 | Grant or award · Option (Right to buy) | +25,000 | 25,000 | D | ||
Loading xslF345X05/form4-02182025_050218.xml…